i-SEP Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$340K
- Investors
-
4
i-SEP General Information
Description
Developer of intraoperative blood auto-transfusers designed to aid during surgical operations. The company's transfusers recover, treat, concentrate, and re-transfuse the blood of surgical patients, avoiding the risks of compatibility, contamination, and postoperative complications, enabling patients to recover from both red blood cells and platelets within the operating room during hemorrhagic surgical procedures.
Contact Information
Website
www.i-sep.comCorporate Office
- 21 Rue de la Noue Bras De Fer
- 44200 Nantes
- France
Corporate Office
- 21 Rue de la Noue Bras De Fer
- 44200 Nantes
- France
i-SEP Timeline
i-SEP Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Equity Crowdfunding | 01-Jan-2026 | $340K | Completed | Generating Revenue | ||
| 9. Later Stage VC | 21-Sep-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 15-Sep-2020 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 14-Oct-2019 | Completed | Generating Revenue | |||
| 6. Grant | 25-Oct-2018 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 09-May-2017 | Completed | Generating Revenue | |||
| 3. Equity Crowdfunding | 27-Apr-2017 | Completed | Startup | |||
| 2. Seed Round | 01-Oct-2015 | $968K | $968K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
i-SEP Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| AP2023-A | ||||||||
| APOS-212 | ||||||||
| AP06-2019 | 408,031 | $0.107563 | $5.63 | $5.63 | 1x | $5.63 | 12.71% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
i-SEP Signals
i-SEP Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GwenneG | VC-Backed Company | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| WiSeed (France) | Corporation | Minority | ||
| GO Capital | Venture Capital | Minority |
i-SEP FAQs
-
When was i-SEP founded?
i-SEP was founded in 2015.
-
Where is i-SEP headquartered?
i-SEP is headquartered in Nantes, France.
-
What is the size of i-SEP?
i-SEP has 32 total employees.
-
What industry is i-SEP in?
i-SEP’s primary industry is Surgical Devices.
-
Is i-SEP a private or public company?
i-SEP is a Private company.
-
What is i-SEP’s current revenue?
The current revenue for i-SEP is .
-
How much funding has i-SEP raised over time?
i-SEP has raised $19.6M.
-
Who are i-SEP’s investors?
GwenneG, Bpifrance, WiSeed (France), and GO Capital have invested in i-SEP.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process